|
The symposium was held at UNMC last week and also included investigators from:
- Beijing Institutes of Life Science of Chinese Academy of Sciences;
- Graduate University of Chinese Academy of Sciences;
- Beijing Anzhen Hospital of Capital University of Medical Sciences;
- Chinese Academy of Medical Sciences; and
- Harvard Medical School.
The U.S.-China CLS is a partnership between UNMC and Chinese Academy of Sciences that promotes research collaboration.
The partnership has been very successful culturally and educationally as well as from scientific and business perspectives, said Le Kang, Ph.D., director-general and president of Beijing Institutes of Life Science and Chinese Academy of Sciences, who attended the symposium at UNMC.
The partnership has increased the UNMC’s international visibility and reputation and helped the medical center establish “solid science relationships” with its international colleagues, said UNMC Chancellor Harold M. Maurer, M.D.
The first symposium was held last year in Beijing.
This year’s symposium focused on issues such as cancer, immunology and development.
The following UNMC researchers participated in the symposium:
- Iqbal Ahmad, Ph.D.;
- Hamid Band, M.D., Ph.D.;
- Surinder Batra, Ph.D.;
- John Chan, M.D.;
- Ken Cowan, M.D., Ph.D.;
- Kia Fu, M.D., Ph.D.;
- Howard Gendelman, M.D.;
- David Li, Ph.D.;
- Tom Rosenquist, Ph.D.;
- Nora Sarvetnick, Ph.D.;
- Rakesh Singh, Ph.D.;
- Jialin Zheng, M.D.;
- Zhixin “Jason” Zhang, Ph.D.; and
- Irving Zucker, Ph.D.